SCHEMBL9056789

SCHEMBL9056789

CCCCCCP(=O)(O)COc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
CETP P11597 6/20 0.59
LTA4H P09960 2/20 0.46
MLNR O43193 1/20 0.44
NR1I2 O75469 1/20 0.44
ESR1 P03372 1/20 0.44
NR3C1 P04150 1/20 0.44
PGR P06401 1/20 0.44
ADRB2 P07550 1/20 0.44
CHRM2 P08172 1/20 0.44
ADRB1 P08588 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
DRD2 P14416 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
CHRM3 P20309 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL887619 0.80 LTA4H (0.66) LTA4HMLNRNR1I2ESR1NR3C1
Phosphoric Acid SCHEMBL2836396 0.80 LTA4H (0.66) LTA4HMLNRNR1I2ESR1NR3C1
Phosphoric Acid SCHEMBL206907 0.80 LTA4H (0.66) LTA4HMLNRNR1I2ESR1NR3C1
Phosphoric Acid SCHEMBL25417010 0.79 LTA4H (0.64) LTA4HMLNRNR1I2ESR1NR3C1
Phosphoric Acid SCHEMBL28734640 0.79 LTA4H (0.64) LTA4HMLNRNR1I2ESR1NR3C1
Phosphoric Acid SCHEMBL6834893 0.79 LTA4H (0.64) LTA4HMLNRNR1I2ESR1NR3C1
SCHEMBL8729121 0.78 S1PR1 (0.50) CETPSLC6A4
SCHEMBL8758199 0.78 S1PR1 (0.50) CETPSLC6A4
Phosphoric Acid SCHEMBL30428 0.78 LTA4H (0.68) LTA4HFDPSFAAH
Phosphoric Acid SCHEMBL28004820 0.78 LTA4H (0.62) LTA4HMLNRNR1I2ESR1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996004234-A1 ARYLOXY ANDARYCTHIO PROPANOLAMINE DERIVATIVES USEFUL AS B3-ADRENORECEPTOR AGONISTS AND ANTAGONS OF THE B1 AND B2 ADRENORECEPTORS AND PHARMACEUTICAL COMPOSITION THEREOF SMITHKLINE BEECHAM PLC (GB) 1996-02-15 WO disclosed